Literature DB >> 20737569

Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification.

Hye Seong Ahn1, Hyuk-Joon Lee, Seokyung Hahn, Woo-Ho Kim, Kuhn Uk Lee, Takeshi Sano, Stephen B Edge, Han-Kwang Yang.   

Abstract

BACKGROUND: The seventh TNM staging system for gastric cancer of the American Joint Committee on Cancer/International Union Against Cancer (AJCC/UICC) had a more detailed classification than the sixth TNM staging system for both the tumor (T) and lymph nodes (N). The authors compared survival rates assessed by the seventh staging system with those by the sixth system.
METHODS: The authors analyzed the prospectively collected database on patients with gastric cancer who underwent surgery at Seoul National University Hospital between 1986 and 2006, and calculated the survival rates of 9998 cases with primary cancer, R0 resection, and >14 retrieved lymph nodes.
RESULTS: The 5-year cumulative survival rates (5YSR) according to the seventh edition T or N classifications were significantly different. The 5YSR according to seventh edition of the TNM staging system were 95.1% (stage IA), 88.4% (stage IB), 84.0% (stage IIA), 71.7% (stage IIB), 58.4% (stage IIIA), 41.3% (stage IIIB), and 26.1% (stage IIIC), which were significantly different from each other. The 5YSR of the seventh edition T2 and T3 classifications had significant differences in patients with every N classification, and the 5YSR of seventh edition N1 and N2 classifications had significant differences in T2 patients, T3 patients, and T4 patients. Each stage in the sixth edition was divided into the seventh edition stage with different survival rates. In addition, the number of homogenous groupings in seventh edition TNM stages was increased from 1 to 2.
CONCLUSIONS: The seventh system provided a more detailed classification of prognosis than the sixth system, especially between T2 and T3 tumors and N1 and N2 tumors, although further studies were found to be needed for the N3a and N3b classification.
Copyright © 2010 American Cancer Society.

Entities:  

Mesh:

Year:  2010        PMID: 20737569     DOI: 10.1002/cncr.25550

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  77 in total

1.  Long-term outcomes after laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective study.

Authors:  Do Joong Park; Sang-Uk Han; Woo Jin Hyung; Min Chan Kim; Wook Kim; Seong Yeob Ryu; Seung-Wan Ryu; Kyo Young Song; Hyuk-Joon Lee; Gyu-Seok Cho; Hyung-Ho Kim
Journal:  Surg Endosc       Date:  2011-12-15       Impact factor: 4.584

2.  Outcomes of minimally invasive surgery for early gastric cancer are comparable with those for open surgery: analysis of 1,013 minimally invasive surgeries at a single institution.

Authors:  Seung-Young Oh; Sebastianus Kwon; Kyung-Goo Lee; Yun-Suhk Suh; Hwi-Nyeong Choe; Seong-Ho Kong; Hyuk-Joon Lee; Woo Ho Kim; Han-Kwang Yang
Journal:  Surg Endosc       Date:  2013-11-22       Impact factor: 4.584

3.  Superiority of the 8th edition of the TNM staging system for predicting overall survival in gastric cancer: Comparative analysis of the 7th and 8th editions in a monoinstitutional cohort.

Authors:  Hao Wang; Weihong Guo; Yanfeng Hu; Tingyu Mou; Liying Zhao; Hao Chen; Tian Lin; Tuanjie Li; Jiang Yu; Hao Liu; Guoxin Li
Journal:  Mol Clin Oncol       Date:  2018-07-26

Review 4.  N staging system: tumor-node-metastasis and future perspectives.

Authors:  Federica Galli; Laura Ruspi; Alessandro Marzorati; Matteo Lavazza; Giuseppe Di Rocco; Luigi Boni; Gianlorenzo Dionigi; Stefano Rausei
Journal:  Transl Gastroenterol Hepatol       Date:  2017-01-17

5.  Comparison of the survival difference between AJCC 6th and 7th editions for gastric cancer patients.

Authors:  Wen-Liang Fang; Kuo-Hung Huang; Jen-Hao Chen; Su-Shin Lo; Mao-Chih Hsieh; King-Han Shen; Anna Fen-Yau Li; Dau-Ming Niu; Shih-Hwa Chiou; Chew-Wun Wu
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

6.  New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points.

Authors:  Takeshi Sano; Takashi Aiko
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

7.  Evaluation of laparoscopic total gastrectomy for advanced gastric cancer: results of a comparison with laparoscopic distal gastrectomy.

Authors:  Jian-Xian Lin; Chang-Ming Huang; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Lu Jun; Qi-Yue Chen; Mi Lin; Ruhong Tu
Journal:  Surg Endosc       Date:  2015-07-25       Impact factor: 4.584

8.  Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis.

Authors:  Y Wang; J Zhang; S Guo; Z Dong; X Meng; G Zheng; D Yang; Z Zheng; Y Zhao
Journal:  Clin Transl Oncol       Date:  2019-03-22       Impact factor: 3.405

Review 9.  Adjuvant therapy for locally advanced gastric cancer.

Authors:  Toru Aoyama; Takaki Yoshikawa
Journal:  Surg Today       Date:  2017-03-01       Impact factor: 2.549

10.  Sixth and seventh tumor-node-metastasis staging system compared in gastric cancer patients.

Authors:  Tommaso Zurleni; Elson Gjoni; Andrea Ballabio; Roberto Casieri; Paola Ceriani; Luca Marzoli; Francesco Zurleni
Journal:  World J Gastrointest Surg       Date:  2013-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.